PROCEPT BioRobotics (NASDAQ: PRCT) has been assigned a neutral rating by BTIG Research, reflecting a cautious outlook for the company. The rating was reissued in a...
Corcept Therapeutics Incorporated (NASDAQ:CORT) has received an average consensus rating of “Buy” from five brokerage firms currently covering the stock, according to Marketbeat Ratings. Analysts have...
Corcept Therapeutics Incorporated (NASDAQ:CORT) has received a consensus rating of “Buy” from the five brokerage firms currently covering its stock, according to a report by Marketbeat...
Research analysts at Mizuho have initiated coverage on shares of Primoris Services (NASDAQ: PRIM), assigning the construction company a “neutral” rating along with a price target...
Research analysts from Mizuho have initiated coverage on shares of Primoris Services (NASDAQ:PRIM), issuing a report on Thursday that assigns a “neutral” rating along with a...
